Excellent. Thanks for sharing. Changing my sentiment to BUY and bought back in a couple of weeks ago. LVT revenue is building, as is the SP. Could be over $1.50 by year end. Gracie
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025